QuiVad

Home / Belgium / Ablynx

Ablynx

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 6.61% on January 22, 2018. The shaded band is the year shown above.

May 21, 2015 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

204 disclosures on record for this share.
DateFund% of capitalEnd of publication
May 16, 2018Sculptor Capital Management Europe Limited1.59%May 18, 2018
May 14, 2018Sculptor Capital Management Europe Limited1.61%May 16, 2018
April 25, 2018Sculptor Capital Management Europe Limited1.52%May 14, 2018
April 24, 2018Sculptor Capital Management Europe Limited1.47%April 25, 2018
April 23, 2018Castle Creek Arbitrage LLC0.90%May 14, 2018
April 13, 2018Castle Creek Arbitrage LLC1.43%April 23, 2018
April 12, 2018Castle Creek Arbitrage LLC1.61%April 13, 2018
March 29, 2018Sculptor Capital Management Europe Limited1.39%April 24, 2018
March 22, 2018Sculptor Capital Management Europe Limited1.02%March 29, 2018
March 16, 2018Sculptor Capital Management Europe Limited0.92%March 22, 2018
March 15, 2018Sculptor Capital Management Europe Limited0.81%March 16, 2018
February 7, 2018Sculptor Capital Management Europe Limited0.76%March 15, 2018
February 5, 2018Sculptor Capital Management Europe Limited0.82%February 7, 2018
January 31, 2018Myriad Opportunities Master Fund Limited0.55%February 1, 2018
January 30, 2018Bluecrest Capital Management LLP0.60%February 2, 2018
January 29, 2018Myriad Opportunities Master Fund Limited0.60%January 31, 2018
January 26, 2018Myriad Opportunities Master Fund Limited0.70%January 29, 2018
January 24, 2018CQS (UK) LLP0.92%February 8, 2018
January 24, 2018Bluecrest Capital Management LLP0.55%January 30, 2018
January 22, 2018CQS (UK) LLP0.86%January 24, 2018
January 22, 2018Citadel Europe LLP0.58%January 30, 2018
January 19, 2018BNP Paribas SA0.51%February 2, 2018
January 11, 2018Bluecrest Capital Management LLP0.65%January 24, 2018
January 10, 2018Myriad Opportunities Master Fund Limited0.69%January 26, 2018
January 9, 2018Sculptor Capital Management Europe Limited1.03%February 5, 2018
January 9, 2018Citadel Europe LLP0.81%January 22, 2018
January 9, 2018Linden Advisors LP0.51%March 29, 2018
January 8, 2018Citadel Europe LLP1.03%January 9, 2018
January 8, 2018Sculptor Capital Management Europe Limited0.86%January 9, 2018
January 8, 2018Bluecrest Capital Management LLP0.70%January 11, 2018
January 8, 2018Myriad Opportunities Master Fund Limited0.70%January 10, 2018
January 5, 2018Castle Creek Arbitrage LLC1.78%April 12, 2018
December 15, 2017BNP Paribas SA0.53%January 16, 2018
December 14, 2017Bluecrest Capital Management LLP0.84%January 8, 2018
December 11, 2017Castle Creek Arbitrage LLC1.50%January 5, 2018
November 30, 2017Castle Creek Arbitrage LLC1.43%December 11, 2017
November 30, 2017Myriad Opportunities Master Fund Limited0.63%January 8, 2018
November 30, 2017GSA Capital Partners LLP0.50%January 9, 2018
November 28, 2017Castle Creek Arbitrage LLC1.35%November 30, 2017
November 28, 2017Numeric Investors LLC0.59%December 11, 2017
November 28, 2017Linden Advisors LP0.54%November 30, 2017
November 24, 2017Linden Advisors LP0.95%November 28, 2017
November 24, 2017BNP Paribas SA0.66%December 15, 2017
November 23, 2017Bluecrest Capital Management LLP0.75%December 14, 2017
November 22, 2017Myriad Opportunities Master Fund Limited0.54%November 30, 2017
November 21, 2017Castle Creek Arbitrage LLC0.90%November 28, 2017
November 20, 2017Linden Advisors LP1.10%November 24, 2017
November 20, 2017Marshall Wace LLP0.54%November 21, 2017
November 16, 2017Castle Creek Arbitrage LLC0.70%November 21, 2017
November 14, 2017Linden Advisors LP1.06%November 20, 2017

Other companies sold short in Belgium

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Ablynx, source FSMA, data as at May 16, 2018, https://www.quivad.com/action/ablynx